David B. Elsbree - 13 Sep 2024 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Reporting relationship: Director
Issuer ticker: TTOO
Reported as of: 13 Sep 2024
Net transaction value: -$133
SEC form: 4
Accepted by SEC: 17 Sep 2024, 17:00:21 UTC
Prior SEC filing: 11 Oct 2023
Next SEC filing: 02 Jan 2025
Source filing: View source filing
Reporting owner signature: /s/ John Sprague, Attorney-in-Fact

Key filing fact

David B. Elsbree filed Form 4 for T2 Biosystems, Inc. (TTOO) on 17 Sep 2024.

Key facts

This page summarizes David B. Elsbree's Form 4 filing for T2 Biosystems, Inc. (TTOO).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 17 Sep 2024, 17:00.

Change

Previous filing in this sequence was filed on 11 Oct 2023.
Current net transaction value: -$133.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TTOO transaction

Common Stock

Sale

Transaction value: $133
Shares: -55
Change %: -71%
Price: $2.42
Shares after: 23
Date: 13 Sep 2024
Ownership: Direct

TTOO holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 2
Date: 13 Sep 2024
Ownership: By spouse
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The reporting person disclaims ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.